ACQUIRED RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE BY PHENOTYPIC PLASTICITY OF MELANOMA

被引：0
|
作者：
Robitschek, Emily [1 ]
Mehta, Arnav [2 ]
Lin, Jia-Ren [3 ]
Frederick, Dennie [4 ]
Shi, Alvin [5 ]
Larque, Ana [6 ]
Miao, Benchun [2 ]
Raghavan, Rumya [7 ]
Sharova, Tatyana [2 ]
Shin, John [2 ]
Kellis, Manolis [5 ]
Hacohen, Nir [4 ]
Flaherty, Keith [2 ]
Boland, Genevieve [2 ]
Chebib, Ivan [2 ]
Liu, David [1 ]
Sullivan, Ryan [2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[5] MIT, Boston, MA USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Broad Inst Harvard & MIT, Cambridge, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0916
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
916
引用
收藏
页码：A955 / A955
页数：1
相关论文
共 50 条
  • [31] Next targets for immune checkpoint blockade in melanoma.
    Chauvin, Joe-Marc
    Ka, Mignane
    Pagliano, Ornella
    Foucade, Julien
    Menna, Carmine
    Davar, Diwakar
    Kirkwood, John
    Kuchroo, Vijay
    Anderson, Ana
    Korman, Alan
    Zarour, Hassane
    CANCER RESEARCH, 2020, 80 (19) : 16 - 16
  • [32] Predictors of responses to immune checkpoint blockade in advanced melanoma
    N. Jacquelot
    M. P. Roberti
    D. P. Enot
    S. Rusakiewicz
    N. Ternès
    S. Jegou
    D. M. Woods
    A. L. Sodré
    M. Hansen
    Y. Meirow
    M. Sade-Feldman
    A. Burra
    S. S. Kwek
    C. Flament
    M. Messaoudene
    C. P. M. Duong
    L. Chen
    B. S. Kwon
    A. C. Anderson
    V. K. Kuchroo
    B. Weide
    F. Aubin
    C. Borg
    S. Dalle
    O. Beatrix
    M. Ayyoub
    B. Balme
    G. Tomasic
    A. M. Di Giacomo
    M. Maio
    D. Schadendorf
    I. Melero
    B. Dréno
    A. Khammari
    R. Dummer
    M. Levesque
    Y. Koguchi
    L. Fong
    M. Lotem
    M. Baniyash
    H. Schmidt
    I. M. Svane
    G. Kroemer
    A. Marabelle
    S. Michiels
    A. Cavalcanti
    M. J. Smyth
    J. S. Weber
    A. M. Eggermont
    L. Zitvogel
    Nature Communications, 8
  • [33] IMMUNE CHECKPOINT BLOCKADE IS ACTIVE IN MELANOMA BRAIN METASTASES
    不详
    CANCER DISCOVERY, 2018, 8 (06) : 672 - 672
  • [34] An angiogenic target of immune exclusion with checkpoint blockade in melanoma
    Tabasum, Saba
    Thapa, Dinesh
    Giobbie-Hurder, Anita
    Weirather, Jason L.
    Wu, Xinqi
    Campisi, Marco
    Li, Xiaoyun
    Li, Jingjing
    Manos, Michael P.
    Barbie, David A.
    Hodi, F. Stephen
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Hypogonadism in melanoma patients under immune checkpoint blockade
    de Vos, L.
    Fietz, S.
    Fetter, T.
    Hillebrand, P.
    Allam, P.
    Landsberg, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 105 - 105
  • [36] Dissecting Response and Resistance to Immune Checkpoint Blockade
    Liu, David
    ONCOLOGIST, 2018, 23 : S4 - S4
  • [37] Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade
    Lotsberg, Maria L.
    Rayford, Austin
    Thiery, Jean Paul
    Belleggia, Giuliana
    Peters, Stacey D'Mello
    Lorens, James B.
    Chouaib, Salem
    Terry, Stephane
    Engelsen, Agnete S. T.
    CANCER DRUG RESISTANCE, 2020, 3 (04) : 832 - 853
  • [38] Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
    Koch, Elias A. T.
    Petzold, Anne
    Wessely, Anja
    Dippel, Edgar
    Gesierich, Anja
    Gutzmer, Ralf
    Hassel, Jessica C.
    Haferkamp, Sebastian
    Kaehler, Katharina C.
    Knorr, Harald
    Kreuzberg, Nicole
    Leiter, Ulrike
    Loquai, Carmen
    Meier, Friedegund
    Meissner, Markus
    Mohr, Peter
    Pfoehler, Claudia
    Rahimi, Farnaz
    Schadendorf, Dirk
    Schell, Beatrice
    Schlaak, Max
    Terheyden, Patrick
    Thoms, Kai-Martin
    Schuler-Thurner, Beatrice
    Ugurel, Selma
    Ulrich, Jens
    Utikal, Jochen
    Weichenthal, Michael
    Ziller, Fabian
    Berking, Carola
    Heppt, Markus V.
    German Dermatologic Cooperat Oncol Grp
    CANCERS, 2022, 14 (03)
  • [39] EVOLUTION OF HLA HAPLOTYPE LOSS IN MELANOMA PATIENTS AND ITS ASSOCIATION WITH RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE
    Zhao, Fang
    Schwamborn, Marion
    Thier, Beatrice
    Crivello, Pietro
    Heinold, Andreas
    Ahci-Hanci, Mueberra
    Meurer, Thuja
    Lennerz, Volker
    Sucker, Antje
    Griewank, Klaus
    Horn, Peter A.
    Ugurel, Selma
    Woelfel, Thomas
    Fleischhauer, Katharina
    Schadendorf, Dirk
    Paschen, Annette
    HLA, 2019, 93 (05) : 273 - 273
  • [40] NFATC2 target gene signature correlates with immune checkpoint blockade resistance in melanoma
    Lawal, Bashir
    Wang, Yue
    Lotfinejad, Parisa
    Sharma, Renu
    Yang, Chuang
    Annasamudram, Anusha
    Wang, Xiao-Song
    AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (01):
12345